Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 is displayed, replacing v3.3.1. No changes to study details or results are observed.SummaryDifference0.0%
- Check21 days agoChange DetectedThe site version updates from v3.2.0 to v3.3.1. There are no visible changes to study data, content, or page functionality.SummaryDifference0.0%
- Check29 days agoChange DetectedDeletion removes a government funding status notice about NIH Clinical Center operations; it does not affect the study details or other core content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check43 days agoChange DetectedThe screenshots show minor formatting changes (layout or styling) without altering the study's actual details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check79 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content shifts to the newer release identifier; no other substantive content changes are indicated.SummaryDifference0.1%
Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.